Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.
about
Antiangiogenic mechanisms and factors in breast cancer treatmentPreventing bone complications in advanced prostate cancerProgrammable multivalent display of receptor ligands using peptide nucleic acid nanoscaffolds.Anti-angiogenic peptides for cancer therapeuticsPhase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortiumDevelopment of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancerStructure-activity relationship study of collagen-derived anti-angiogenic biomimetic peptidesIn vitro and in vivo drug disposition of cilengitide in animals and human.RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer-going beyond PSA and imaging, a systematic literature review.Systemic Delivery of Tumor-Targeted Bax-Derived Membrane-Active Peptides for the Treatment of Melanoma Tumors in a Humanized SCID Mouse Model.The effect of cilengitide in combination with irradiation and chemotherapy in head and neck squamous cell carcinoma cell lines.Peptides and peptidomimetics as regulators of protein-protein interactions.α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo Pathway.Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model.Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET.Proteolytic fragments of fibronectin function as matrikines driving the chemotactic affinity of prostate cancer cells to human bone marrow mesenchymal stromal cells via the α5β1 integrin.Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed-effects analysis.Bone-Targeted Therapies in Cancer-Induced Bone Disease.Access to site-specific Fc-cRGD peptide conjugates through streamlined expressed protein ligation.Integrin Inhibitors in Prostate Cancer.
P2860
Q26751226-D9DED066-5D66-430C-A77F-41CB8FFDEE4DQ34111634-C1E366E0-81FC-4563-9BC0-23BE9D35D41EQ34123096-5481D4BD-766D-4F2B-9316-D8DDF321DEC4Q35043016-C3B72926-9170-464E-8092-90F55997C477Q35218871-1086F869-4F15-4054-A832-BECF453D6DBAQ35577780-C59AEE7E-63E0-4D7D-94FA-E3814C0A8924Q36020002-AE0A6E9B-E29D-4129-BC60-22234867FD2CQ36719621-638056EC-679D-47B4-B509-0862D31D2CDBQ38161395-D0C16A9C-5EA7-49C3-80E8-ECB2F1673F39Q38555581-1210132C-6B0D-4EDD-86DB-F167BD6A7661Q38718291-5747FD82-56FC-4B56-9ADD-7C4510BCFFCAQ39021996-C6A06A4B-FC3C-4CF7-86F7-67B432D31967Q39072845-B6D083CC-32F7-49F6-BEF0-7D725282C8D5Q39343833-D5ECF2DA-D232-42C7-BDDF-61F2D9A19AE5Q39649606-C9DA3750-ECCA-45EA-8F9D-38D2AF35BC83Q41354108-27FF41A8-80F9-4358-A613-8D3B4439FAFDQ41510265-1E69067A-931E-4022-B6DF-C9D3A68A4B26Q46894458-C42D2BF8-EFD8-4D66-84E8-D0ED78284892Q48110513-E770B616-6DB1-4CB2-A79F-155AE8546263Q48310799-389F2517-CA1C-4D66-AED4-C341C761169AQ50132111-549C7678-5705-411B-9F02-C36B289C5D45
P2860
Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cilengitide (EMD 121974, NSC 7 ...... er clinical trials consortium.
@en
type
label
Cilengitide (EMD 121974, NSC 7 ...... er clinical trials consortium.
@en
prefLabel
Cilengitide (EMD 121974, NSC 7 ...... er clinical trials consortium.
@en
P2093
P2860
P50
P1476
Cilengitide (EMD 121974, NSC 7 ...... er clinical trials consortium.
@en
P2093
Alice Chen
Charles J Ryan
Deborah A Bradley
Eric Small
Evan T Keller
Gerald Doyle
June Escara-Wilke
Maha Hussain
Mahmoud Al-Hawary
Mark N Stein
P2860
P2888
P304
P356
10.1007/S10637-010-9420-8
P577
2010-03-25T00:00:00Z
P5875
P6179
1020631030